Retinoic acid-induced growth arrest and differentiation: Retinoic acid up-regulates CD32 (FcγRII) expression, the ectopic expression of which retards the cell cycle

Molecular Cancer Therapeutics

Volumn 1, Issue 7, 2002, Pages 493-506

  Wightman, Jenifer ^a   Roberson, Mark S ^a   Lamkin, Thomas J ^a   Varvayanis, Susi ^a   Yen, Andrew ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CROSS LINKING REAGENT; FC RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHOTYROSINE; RETINOIC ACID; RNA;

ARTICLE; BIOSYNTHESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL MEMBRANE; CELL STRAIN HL 60; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; METABOLISM; MUTATION; NORTHERN BLOTTING; PHOSPHORYLATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; TIME; UPREGULATION; WESTERN BLOTTING;

BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL MEMBRANE; CROSS-LINKING REAGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION PROFILING; GENETIC VECTORS; HL-60 CELLS; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MUTATION; PHOSPHORYLATION; PHOSPHOTYROSINE; RECEPTORS, IGG; RNA; TIME FACTORS; TRANSFECTION; TRETINOIN; UP-REGULATION;

EID: 0036560276     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Sklan, D. Vitamin A in human nutrition. Prog. Food Nut. Sci., 11: 39-55, 1987. (Pubitemid 17135107)
2. Blomhoff, R., Green, M. H., Berg, T., and Norum, K. Transport and storage of vitamin A. Science (Wash. DC), 250: 399-403, 1990.
3. Gudas, L. J. Retinoids and vertebrate development. J. Biol. Chem., 22: 15399-15402, 1994. (Pubitemid 24202115)
4. Friedman, A., and Sklan, D. Vitamin A and immunity. In: D. M. Klurfeld (ed.), Human Nutrition - A Comprehensive Treatise, Vol. 8, pp. 197-216. New York, NY: Plenum Press, 1993.
5. Flynn, P. J., Miller, W. J., Weisdorf, J. D., Arthur, D. C., Brunning, R., and Branda, R. F. Retinoic acid treatment of acute promyelocytic leukemia: in vitro and in vivo observations. Blood, 62: 1211-1217, 1983. (Pubitemid 14209668)
6. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (Lond.), 345: 224-229, 1990.
7. Mangelsdorf, D. J., Borgmeyer, U., Heyman, R. A., Zhou, J. Y., Ong, E. S., Oro, A. E., Kakizuka, A., and Evans, R. M. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid. Genes Dev., 6: 329-344, 1992.
8. Mangelsdorf, D. J., Umesono, K., U., and Evans, R. M. The retinoid receptors. In: M. B. Sporn, A. Roberts, and D. S. Goodman (eds.), The Retinoids, Ed. 2, pp. 319-349. New York: Raven Press, 1994.
9. Yen, A., Roberson, M. S., Varvayanis, S., and Lee, A. T. Retinoic acid induces mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinase-dependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res., 58: 3163-3172, 1998. (Pubitemid 28335101)
10. Yen, A., Cherington, V., Schaffhausen, B., Marks, K., and Varvayanis, S. Transformation defective polyoma middle T antigen mutants defective in PLCγ. PI-3 or SRC kinase activation enhance ERK2 activation and promote retinoic acid-induced cell differentiation like wild type middle T. Exp. Cell Res., 248: 538-551, 1999. (Pubitemid 29394813)
11. Yen, A., Roberson, M. S., and Varvayanis, S. Retinoic acid selectively activates the ERK2 but not JNK/SAPK or p38 MAP kinases when inducing myeloid differentiation. In Vitro Cell. Dev. Biol., 35: 527-532, 1999. (Pubitemid 29530103)
12. Battle, T. E., Levine, R. A., and Yen, A. Retinoic acid-induced BLR1 expression promotes ERK2 activation and cell differentiation in HL-60 cells. Exp. Cell Res., 254: 287-298, 2000. (Pubitemid 30080585)
13. 3 analogs activating ERK2 in HL-60 cells show that retinoic acid-induced differentiation and cell cycle arrest require early concurrent MAPK and RAR and RXR activation. In Vitro Cell. Dev. Biol. Animal, 37: 93-99, 2001.
14. Hong, H. Y., Varvayanis, S., and Yen, A. Retinoic acid causes MEK-dependent RAF phosphorylation through RARα plus RXR activation in HL-60 cells. Differentiation (Camb.), 68: 55-66, 2001. (Pubitemid 34203528)
15. Yen, A., Sturgill, R., and Varvayanis, S. Retinoic acid increases amount of phosphorylated RAF. Ectopic expression of cFMS reveals that retinoic acid induced differentiation is more strongly dependent on ERK2 signaling than induced G0 arrest is. In Vitro Cell. Dev. Biol., 36: 249-255, 2000. (Pubitemid 30368363)
16. Katagiri, K., Katagiri, T., Koyama, Y., Morikawa, M., Yamamoto, T., and Yoshida, T. Expression of src family genes during monocytic differentiation of HL-60 Cells. J. Immunol., 146: 701-707, 1991.
17. Katagiri, K., Yokoyama-Kazunari, Y., Yamamoto-Tadashi, K., Omura, S., Shinkichi, I., and Katagiri, T. Lyn and Fgr protein-tyrosine kinases prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J. Biol. Chem., 271: 11557-11562, 1996. (Pubitemid 26156001)
18. Linnekin, D., Howard, O. M. Zack, Park, L., Farrar, W., Ferris, D., and Longo, D. L. Hck expression correlates with granulocyte-macrophage colony-stimulating factor-induced proliferation in HL-60 cells. Blood, 84: 94-103, 1994. (Pubitemid 24193809)
19. Platko, J. D., and Yen, A. Paxillin increases as retinoic acid or vitamin D3 induce HL-60 cell differentiation. In Vitro Cell. Dev. Biol., 33: 84-87, 1997. (Pubitemid 27149159)
20. Alsayad, Y., Modi, S., Uddin, S., Mahmud, N., Druker, B. J., Fish, E. N., Hoffman, R., and Platanias-Leonidas, C. All-trans-retinoic acid induces tyrosine phosphorylation of the Crkl adapter in acute promyelocytic leukemia cells. Exp. Hematol., 28: 826-832, 2000. (Pubitemid 30411988)
21. Bertagnolo, V., Marchisio, M., Volinia, S., Caramelli, E., and Capitani, S. Nuclear association of tyrosine-phosphorylated Vav to phospholipase C-γ1 and phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells. FEBS Lett., 441: 480-484, 1998. (Pubitemid 29065339)
22. Bertagnolo, V., Marchisio, M., Brugnoli, F., Bavelloni, A., Boccafogli, L., Colamussi, M. L., and Capitani, S. Requirement of tyrosine-phosphorylated Vav for morphological differentiation of all-trans-retinoic acid-treated HL-60 cells. Cell Growth Differ., 12: 193-200, 2001. (Pubitemid 32678232)
23. Collins, S. J., Gallo, R. C., and Gallagher, R. E. Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture. Nature (Lond.), 270: 347-349, 1977.
24. Breitman, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980. (Pubitemid 10049852)
25. Yen, A. HL-60 cells as a model of growth control and differentiation: the significance of variant cells. Hematol. Rev., 4: 5-46, 1990. (Pubitemid 20188267)
26. Yen, A., Reece, S. L., and Albright, K. L. Dependence of HL-60 myeloid cell differentiation on continuous and split retinoic acid exposures: pre-commitment memory associated with altered nuclear structure. J. Cell. Physiol., 118: 227-286, 1984.
27. Yen, A., Forbes, M., de Gala, G., and Fishbaugh, J. Control of HL-60 cell differentiation lineage specificity: a late event occurring after precommitment. Cancer Res., 47: 129-134, 1987. (Pubitemid 17002111)
28. Yen, A., Brown, D., and Fishbaugh, J. Precommitment states induced during HL-60 myeloid differentiation: possible similarities of retinoic acid and DMSO induced early events. Exp. Cell Res., 173: 80-84, 1987. (Pubitemid 18011162)
29. Yen, A., and Forbes, M. E. c-myc down regulation and precommitment in HL-60 cells due to bromodeoxyuridine. Cancer Res., 50: 1411-1420, 1990. (Pubitemid 20090449)
30. Wang, X., and Studzinski, G. P. Activation of extracellular signal-regulated kinases (ERKs) defines the first phase of 1, 25-dihydroxyvitamin D3-induced differentiation of HL-60 cells. J. Cell. Biochem., 80: 471-482, 2001. (Pubitemid 32127462)
31. Brooks, S. C., III, Kazmer, S., Levin, A. A., and Yen, A. Myeloid differentiation and RB phosphorylation changes in HL-60 cells induced by RAR- and RXR-selective retinoic acid analogs. Blood, 87: 227-237, 1996.
32. Battle, T. E., Roberson, M. S., Zhang, T., Varvayanis, S., and Yen, A. Retinoic acid-induced BLR1 expression requires RARα, RXR, and MAPK activation and uses ERK2 but not JNK/SAPK to accelerate cell differentiation. Eur. J. Cell Biol., 80: 59-67, 2001. (Pubitemid 32098112)
33. Yen, A., French, T., Russel, K., Varvayanis, S., and Forbes, M. Vitamin A regulated RB tumor suppressor gene expression in leukemic cells. In: Maryce M. Jacobs (ed.) Advances in Experimental Biology and Medicine, Vol. 354, Diet and Cancer: Markers, Prevention and Treatment, pp. 1-18. New York: Plenum Publishing Corp., 1994.
34. Cooper, G. M. Pathways of mitogenic signal transduction. In: Oncogenes, Ed. 2, pp. 279-306. Boston: Jones & Bartlett, 1995.
35. Yen, A., Forbes, M. E., Varvayanis, S., Tykocinski, M. L., Groger, R. K., and Platko, J. D. C-FMS dependent HL-60 cell differentiation and regulation of RB gene expression. J. Cell. Physiol., 157: 379-391, 1993. (Pubitemid 23332783)
36. Yen, A., Sturgill, R., Varvayanis, S., and Chern, R. FMS (CSF-1 receptor) prolongs cell cycle, promotes retinoic acid induced hypophosphorylation of RB protein, G1 arrest and cell differentiation. Exp. Cell Res., 229: 111-125, 1996. (Pubitemid 26423940)
37. Yen, A., Sturgill, R., and Varvayanis, S. Increasing c-FMS expression decreases retinoic acid concentration needed to cause cell differentiation and RB hypophosphorylation. Cancer Res., 57: 2020-2028, 1997. (Pubitemid 27209736)
38. Platko, J. D., Forbes, M. E., Varvayanis, S., Williams, M. N., Brooks, S. C., III, Cherington, V., and Yen, A. Polyoma middle T antigen in HL-60 cells accelerates hematopoietic myeloid and monocytic cell differentiation. Exp. Cell Res., 238: 42-50, 1998. (Pubitemid 28366125)
39. Daëron, M. Fc receptor biology. Annu. Rev. Immunol., 15: 203-234, 1997.
40. Ghazizadeh, S., Bolen, J. B., and Fleit, H. B. Physical and functional association of Src-related protein tyrosine kinases with FcγRII in monocytic THP-1 cells. J. Biol. Chem., 269: 8878-8884, 1994.
41. Hamada, F., Aoki, M., Akiyama, T., and Toyoshima, K. Association of immunoglobulin G Fc receptor II with Src-like protein-tyrosine kinase Fgr in neutrophils. Proc. Natl. Acad. Sci. USA, 90: 6305-6309, 1993. (Pubitemid 23191504)
42. Agarwal, A., Salem, P., and Robbins, K. C. Involvement of p72syk, a protein-tyrosine kinase, in Fcγ receptor signaling. J. Biol. Chem., 268: 15900-15905, 1993. (Pubitemid 23222094)
43. Rouard, H., Tamasdan, S., Fridman, W. H., and Teillaud, J. L. Vav and SLP-76 recruitment by cross-linking of FcγRIIa1 in promyelocytic HL-60 cells. Immunol. Lett., 68: 347-353, 1999. (Pubitemid 29301898)
44. Marcilla, A., Rivero-Lezcano, O. M., Agarwal, A., and Robbins, K. C. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fcγ receptors. J. Biol. Chem., 270: 9115-9120, 1995.
45. Pan, X. Q., Darby, C., Indik, Z. K., and Schreiber, A. D. Activation of three classes of nonreceptor tyrosine kinases following Fcγ receptor crosslinking in human monocytes. Clin. Immunol., 90: 55-64, 1999. (Pubitemid 29162184)
46. Suzuki, T., and Campana, D. CD32 expression and function in human immature B cells. Blood, 96: 11 Part 1 616a, 2000.
47. Brooks, D. G., Qiu, W. Q., Luster, A. D., and Ravetch, J. V. Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes. J. Exp. Med., 170: 1369-1385, 1989. (Pubitemid 19250700)
48. Cepko, C. L., Roberts, B. E., and Mulligan, R. C. Construction and application of a highly transmissible murine retrovirus shuttle vector. Cell, 37: 1053-1062, 1984. (Pubitemid 15139296)
49. Yen, A., Placanica, L., Bloom, S., and Varvayanis, S. Polyoma small T antigen prevents retinoic acid-induced RB hypophosphorylation and redirects retinoic acid-induced G0 arrest and differentiation to apoptosis. J. Virol., 25: 5302-5314, 2001. (Pubitemid 32448552)
50. Lorenzo, P. S., Bögi, K., Ács, P., Pettit, G. R., and Blumberg, P. M. The catalytic domain of protein kinase Cδ confers protection from downregulation induced by bryostatin 1. J. Biol. Chem., 272: 33338-33343, 1997. (Pubitemid 28023684)
51. McKenzie, S. E., Keller, M. A., Cassell, D. L., Schreiber, A. D., Schwartz, E., Surrey, S., and Rappapor, E. F. Characterization of the 5′-flanking transcriptional regulatory region of the human Fcγ receptor gene, FcγRIIA. Mol. Immunol., 29: 1165-1174, 1992.
52. Cassel, D. L., Keller, M. A., Surrey, S., Schwartz, E., Schreiber, A. D., Rappaport, E. F., and McKenzie, S. E. Differential expression of FcγRIIA, FcγRIIB and FcγRIIC in hematopoietic cells: analysis of transcripts. Mol. Immunol., 30: 451-460, 1993.
53. Yen, A., and Pardee, A. B. Exponential 3T3 cells escape in mid-G1 from their high serum requirement. Exp. Cell Res., 116: 103-113, 1978. (Pubitemid 9059395)
54. Yen, A., Williams, M., Platko, J. D., Der, C., and Hisaka, M. Expression of activated RAF accelerates cell differentiation and RB protein down regulation but not hypophosphorylation. Eur. J. Cell Biol., 65: 103-113, 1994. (Pubitemid 24328182)
55. Brooks, S. C., III, Sturgill, R., Choi, J., and Yen, A. An RXR selective analog attenuates the RAR selective analog induced differentiation and non-G1-restricted growth arrest of NB4 cells. Exp. Cell Res., 234: 259-269, 1997. (Pubitemid 27335166) Health